Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Sep;36(9):2179-86.
doi: 10.1007/s00268-012-1638-5.

Long-term survival in hilar cholangiocarcinoma also possible in unresectable patients

Anthony T Ruys  1 , Steven van Haelst, Olivier R Busch, Erik A Rauws, Dirk J Gouma, Thomas M van Gulik
Affiliations

Long-term survival in hilar cholangiocarcinoma also possible in unresectable patients

Anthony T Ruys et al. World J Surg. 2012 Sep.

Abstract

Background: Radical resection remains the only curative treatment for hilar cholangiocarcinoma (HCCA). Only a limited proportion of patients, however, are eligible for resection. The survival and prognostic factors of these patients are largely unknown. The aim of this study was to evaluate survival and prognostic factors in unresectable patients presenting with HCCA.

Methods: We performed a cohort study of the denominator of HCCA patients seen in a tertiary referral center between March 2003 and March 2009. Demographics, treatment, pathology results, and survival were analyzed.

Results: A total of 217 patients with suspected HCCA were identified. Ninety-five patients (40 %) underwent laparotomy, and in 57 (63 %) of these patients resection was performed. Overall median and 5-year survival of resected patients were 37 months and 43 %, respectively, as compared to 13 months and 7 % in unresectable patients. In unresectable patients, median survival was better in patients with locally advanced disease (16 months) as compared to patients with hepatic and extrahepatic metastases (5 and 3 months, p < 0.001). Of the 160 unresectable patients, 17 (10 %) survived longer than 3 years.

Conclusion: Of the patients presenting with HCCA in our center, 26 % proved resectable. The 7 % long-term survival rate of unresectable patients is remarkable and emphasizes the indolent growth of some of these tumors. Patients with metastases had a much worse prognosis with a median of 4 months.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Survival of unresectable and resected patients with HCCA (p < 0.001)
Fig. 2
Fig. 2
Survival of unresectable HCCA patients, stratified according to cause of unresectability
See this image and copyright information in PMC

References

    1. Dinant S, Gerhards MF, Rauws EA, et al. Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumor) Ann Surg Oncol. 2006;13(6):872–880. doi: 10.1245/ASO.2006.05.053. - DOI - PubMed
    1. Ito F, Cho CS, Rikkers LF, et al. Hilar cholangiocarcinoma: current management. Ann Surg. 2009;250(2):210–218. doi: 10.1097/SLA.0b013e3181afe0ab. - DOI - PubMed
    1. Kloek JJ, Ten Kate FJ, Busch OR, et al. Surgery for extrahepatic cholangiocarcinoma: predictors of survival. HPB (Oxford) 2008;10(3):190–195. doi: 10.1080/13651820801992575. - DOI - PMC - PubMed
    1. Connor S, Barron E, Redhead DN, et al. Palliation for suspected unresectable hilar cholangiocarcinoma. Eur J Surg Oncol. 2007;33(3):341–345. doi: 10.1016/j.ejso.2006.11.005. - DOI - PubMed
    1. Ito F, Agni R, Rettammel RJ, et al. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence. Ann Surg. 2008;248(2):273–279. doi: 10.1097/SLA.0b013e31817f2bfd. - DOI - PubMed